Regenerative Therapies Market: Global Industry Analysis And Forecast(2022-2029)


Regenerative Therapies Market size is expected to reach US$ 74.89 Bn. by year 2029 at a CAGR of 11.3% during the forecast period.

Regenerative Therapies Market

To know about the Research Methodology :- Request Free Sample Report

Regenerative therapy is an emerging field of medical science, recent development in biotechnology to improve healing by using the body’s mechanisms. Regenerative Therapies are used in specific applications such as cells or cell products for diseased tissues or organs restoration process. The regenerative therapies are used in laboratories and medical facilities to grow tissues and organs, which can be implanted in the body. Major medical conditions like heart failure, insulin-dependent diabetics, spinal cord injury, and Alzheimer's diseases are advised to address using cell-based therapies.

While some setbacks have unfortunately marked the groundbreaking stage leading to regenerative therapies market growth, thanks to sound commercial products for skin ulcers and sports injury damage to the cartilage of the knee are now available in the market. Treatment of patients with bladder dysfunction is also possible using regenerative therapies. These therapies use either autologous or allogeneic somatic cells, and the drugs have a biomaterial aspect in the case of the skin and bladder.

The report covers the detailed analysis global regenerative therapies with the classifications of the market on the product type, applications, and region. Analysis of past market dynamics from 2021 to 2029 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players' contribution in it.

The report has profiled major key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. The manufacturing environment in each region is different and focus is given on the regional impact on the cost of manufacturing, supply chain, availability of raw materials, labor cost, availability of advanced technology, trusted vendors are analyzed and the report has come up with recommendations for a future hot spot in APAC region. The major country’s policies about the oil and gas industry and its impact on therapies service providers are covered in the report.

Regenerative Therapies Market Dynamics:

The pandemic of chronic diseases, compounded by the scarcity of usable donor organs, are driving the regenerative therapies market growth.

In treating degenerative diseases, regenerative therapies offer innovative solutions. The evolving regenerative armamentarium aims to increase the aptitude of human tissues for self-renewal by exploiting newfound awareness of the intimate processes central to organogenesis and healing. The increasing number of diabetes patients and obesity patient count boosts the demand for regenerative therapies.

In the US, the development of regenerative therapies and medicines under the 21st-century cures act is expected to create an enormous market opportunity for the market players in the nearer future. The US the health department and the government are actively funding research and development of new medicines to fight cancer and heart problems.

Tissue Engineered Products holds a major market share in 2021 and is expected to grow at a CAGR of xx% during the forecast period

The tissue-engineered products are expected to grow at the highest CAGR during the forecast period. Tissue-engineered products are produced from living cells or tissues, with the final product containing feasible or non-feasible cells. Increasing development of medical science and clinical research is expected to grow the application of tissue-engineered products. The Progenitor & Stem Cell Therapies segment is expected to reach US$ xx Mn by 2029. Other segments are covered in the report with the application, drivers, regional market size, share, and condition.

Regenerative Therapies Market Regional Insights

The Asia Pacific commands the Regenerative Therapies market, with a share of xx% in 2021.

The Asia Pacific is leading the Regenerative Therapies market, Thanks to the medical sector growth and increasing contract research outsourcing in countries like China, India, Japan, South Korea, and others. Recently the medical facilities in the Asia Pacific have grown by xx% than the previous year 2021. Highly-skilled local talent and increasing government funding is expected to drive the market during the forecast period. Followed by North America, the countries in North America, such as the US and Canada are increasingly funding the regenerative therapies development, which is driving the market in the region.

The objective of the report is to present a comprehensive analysis of the Global Regenerative Therapies Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Regenerative Therapies Market dynamics, structure by analyzing the market segments and project the Global Regenerative Therapies Market size. Clear representation of competitive analysis of key players By Product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Regenerative Therapies Market make the report investor’s guide.

Regenerative Therapies Market Scope: Inquire before buying

Regenerative Therapies Market, By Product

• Tissue-engineered Products
• Cell Therapies
• Gene Therapies
• Progenitor & Stem Cell Therapies

Regenerative Therapies Market, By Application

• Musculoskeletal
• Oncology
• Wound Care
• Dental
• Ocular
• Other Applications

Regenerative Therapies Market, by Region

• Asia Pacific
• North America
• Europe
• South America
• Middle East & Africa

Regenerative Therapies Market Key players

• Acelity L.P. Inc.
• Mesoblast Ltd.
• Nuo Therapeutics, Inc. (Cytomedix).
• Astellas Pharma US, Inc.
• Organovo Holdings Inc.
• Orgenesis Inc.
• Sanofi.
• Athersys, Inc.
• Shire Pharmaceuticals Limited.
• Cytori Therapeutics Inc.
• Others

Frequently Asked Questions:

1. Which region has the largest share in Global Regenerative Therapies Market?
Ans: Asia Pacific region holds the highest share in 2021.

2. What is the growth rate of Global Regenerative Therapies Market?
Ans: The Global Regenerative Therapies Market is growing at a CAGR of 11.3% during forecasting period 2022-2029.

3. What is scope of the Global Regenerative Therapies market report?
Ans: Global Regenerative Therapies Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Regenerative Therapies market?
Ans: The important key players in the Global Regenerative Therapies Market are – Acelity L.P. Inc., Mesoblast Ltd., Nuo Therapeutics, Inc. (Cytomedix)., Astellas Pharma US, Inc., Organovo Holdings Inc., Orgenesis Inc., Sanofi., Athersys, Inc., Shire Pharmaceuticals Limited., Cytori Therapeutics Inc., and Others

5. What is the study period of this market?
Ans: The Global Regenerative Therapies Market is studied from 2021 to 2029. 




Global Regenerative Therapies Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Regenerative Therapies Market Size, by Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global Regenerative Therapies Market Analysis and Forecast
6.1. Regenerative Therapies Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Regenerative Therapies Market Analysis and Forecast, By Application
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Regenerative Therapies Market Value Share Analysis, By Application
7.4. Global Regenerative Therapies Market Size (US$ Mn) Forecast, By Application
7.5. Global Regenerative Therapies Market Analysis, By Application
7.6. Global Regenerative Therapies Market Attractiveness Analysis, By Application

8. Global Regenerative Therapies Market Analysis and Forecast, By Product
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Regenerative Therapies Market Value Share Analysis, By Brake Used
8.4. Global Regenerative Therapies Market Size (US$ Mn) Forecast, By Brake Used
8.5. Global Regenerative Therapies Market Analysis, By Brake Used
8.6. Global Regenerative Therapies Market Attractiveness Analysis, By Brake Used

9. Global Regenerative Therapies Market Analysis, by Region
9.1. Global Regenerative Therapies Market Value Share Analysis, by Region
9.2. Global Regenerative Therapies Market Size (US$ Mn) Forecast, by Region
9.3. Global Regenerative Therapies Market Attractiveness Analysis, by Region

10. North America Regenerative Therapies Market Analysis
10.1. Key Findings
10.2. North America Regenerative Therapies Market Overview
10.3. North America Regenerative Therapies Market Value Share Analysis, By Application
10.4. North America Regenerative Therapies Market Forecast, By Application
10.4.1. Musculoskeletal
10.4.2. Oncology
10.4.3. Wound Care
10.4.4. Dental
10.4.5. Ocular
10.4.6. Other Applications
10.5. North America Regenerative Therapies Market Value Share Analysis, By Product
10.6. North America Regenerative Therapies Market Forecast, By Product
10.6.1. Tissue-engineered Products
10.6.2. Cell Therapies
10.6.3. Gene Therapies
10.6.4. Progenitor & Stem Cell Therapies
10.7. North America Regenerative Therapies Market Value Share Analysis, by Country
10.8. North America Regenerative Therapies Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.8.3. Mexico
10.9. North America Regenerative Therapies Market Analysis, by Country
10.10. U.S. Regenerative Therapies Market Forecast, By Application
10.10.1. Musculoskeletal
10.10.2. Oncology
10.10.3. Wound Care
10.10.4. Dental
10.10.5. Ocular
10.10.6. Other Applications
10.11. U.S. Regenerative Therapies Market Forecast, By Product
10.11.1. Tissue-engineered Products
10.11.2. Cell Therapies
10.11.3. Gene Therapies
10.11.4. Progenitor & Stem Cell Therapies
10.12. Canada Regenerative Therapies Market Forecast, By Application
10.12.1. Musculoskeletal
10.12.2. Oncology
10.12.3. Wound Care
10.12.4. Dental
10.12.5. Ocular
10.12.6. Other Applications
10.13. Canada Regenerative Therapies Market Forecast, By Product
10.13.1. Tissue-engineered Products
10.13.2. Cell Therapies
10.13.3. Gene Therapies
10.13.4. Progenitor & Stem Cell Therapies
10.14. Mexico Regenerative Therapies Market Forecast, By Application
10.14.1. Musculoskeletal
10.14.2. Oncology
10.14.3. Wound Care
10.14.4. Dental
10.14.5. Ocular
10.14.6. Other Applications
10.15. Mexico Regenerative Therapies Market Forecast, By Product
10.15.1. Tissue-engineered Products
10.15.2. Cell Therapies
10.15.3. Gene Therapies
10.15.4. Progenitor & Stem Cell Therapies
10.16. North America Regenerative Therapies Market Attractiveness Analysis
10.16.1. By Application
10.16.2. By Product
10.17. PEST Analysis
10.18. Key Trends
10.19. Key Developments

11. Europe Regenerative Therapies Market Analysis
11.1. Key Findings
11.2. Europe Regenerative Therapies Market Overview
11.3. Europe Regenerative Therapies Market Value Share Analysis, By Application
11.4. Europe Regenerative Therapies Market Forecast, By Application
11.4.1. Musculoskeletal
11.4.2. Oncology
11.4.3. Wound Care
11.4.4. Dental
11.4.5. Ocular
11.4.6. Other Applications
11.5. Europe Regenerative Therapies Market Forecast, By Product
11.5.1. Tissue-engineered Products
11.5.2. Cell Therapies
11.5.3. Gene Therapies
11.5.4. Progenitor & Stem Cell Therapies
11.6. Europe Regenerative Therapies Market Value Share Analysis, by Country
11.7. Europe Regenerative Therapies Market Forecast, by Country
11.7.1. Germany
11.7.2. U.K.
11.7.3. France
11.7.4. Italy
11.7.5. Spain
11.7.6. Sweden
11.7.7. CIS countries
11.7.8. Rest of Europe
11.8. Germany Regenerative Therapies Market Forecast, By Application
11.8.1. Musculoskeletal
11.8.2. Oncology
11.8.3. Wound Care
11.8.4. Dental
11.8.5. Ocular
11.8.6. Other Applications
11.9. Germany Regenerative Therapies Market Forecast, By Product
11.9.1. Tissue-engineered Products
11.9.2. Cell Therapies
11.9.3. Gene Therapies
11.9.4. Progenitor & Stem Cell Therapies
11.10. U.K. Regenerative Therapies Market Forecast, By Application
11.10.1. Musculoskeletal
11.10.2. Oncology
11.10.3. Wound Care
11.10.4. Dental
11.10.5. Ocular
11.10.6. Other Applications
11.11. U.K. Regenerative Therapies Market Forecast, By Product
11.11.1. Tissue-engineered Products
11.11.2. Cell Therapies
11.11.3. Gene Therapies
11.11.4. Progenitor & Stem Cell Therapies
11.12. France Regenerative Therapies Market Forecast, By Application
11.12.1. Musculoskeletal
11.12.2. Oncology
11.12.3. Wound Care
11.12.4. Dental
11.12.5. Ocular
11.12.6. Other Applications
11.13. France Regenerative Therapies Market Forecast, By Product
11.13.1. Tissue-engineered Products
11.13.2. Cell Therapies
11.13.3. Gene Therapies
11.13.4. Progenitor & Stem Cell Therapies
11.14. Italy Regenerative Therapies Market Forecast, By Application
11.14.1. Musculoskeletal
11.14.2. Oncology
11.14.3. Wound Care
11.14.4. Dental
11.14.5. Ocular
11.14.6. Other Applications
11.15. Italy Regenerative Therapies Market Forecast, By Product
11.15.1. Tissue-engineered Products
11.15.2. Cell Therapies
11.15.3. Gene Therapies
11.15.4. Progenitor & Stem Cell Therapies
11.16. Spain Regenerative Therapies Market Forecast, By Application
11.16.1. Musculoskeletal
11.16.2. Oncology
11.16.3. Wound Care
11.16.4. Dental
11.16.5. Ocular
11.16.6. Other Applications
11.17. Spain Regenerative Therapies Market Forecast, By Product
11.17.1. Tissue-engineered Products
11.17.2. Cell Therapies
11.17.3. Gene Therapies
11.17.4. Progenitor & Stem Cell Therapies
11.18. Sweden Regenerative Therapies Market Forecast, By Application
11.18.1. Musculoskeletal
11.18.2. Oncology
11.18.3. Wound Care
11.18.4. Dental
11.18.5. Ocular
11.18.6. Other Applications
11.19. Sweden Regenerative Therapies Market Forecast, By Product
11.19.1. Tissue-engineered Products
11.19.2. Cell Therapies
11.19.3. Gene Therapies
11.19.4. Progenitor & Stem Cell Therapies
11.20. CIS countries Regenerative Therapies Market Forecast, By Application
11.20.1. Musculoskeletal
11.20.2. Oncology
11.20.3. Wound Care
11.20.4. Dental
11.20.5. Ocular
11.20.6. Other Applications
11.21. CIS countries Regenerative Therapies Market Forecast, By Product
11.21.1. Tissue-engineered Products
11.21.2. Cell Therapies
11.21.3. Gene Therapies
11.21.4. Motor generator
11.21.5. Progenitor & Stem Cell Therapies
11.22. Rest of Europe Regenerative Therapies Market Forecast, By Application
11.22.1. Musculoskeletal
11.22.2. Oncology
11.22.3. Wound Care
11.22.4. Dental
11.22.5. Ocular
11.22.6. Other Applications
11.23. Rest of Europe Regenerative Therapies Market Forecast, By Product
11.23.1. Tissue-engineered Products
11.23.2. Cell Therapies
11.23.3. Gene Therapies
11.23.4. Progenitor & Stem Cell Therapies
11.24. Europe Regenerative Therapies Market Attractiveness Analysis
11.24.1. By Product
11.24.2. By Application
11.25. PEST Analysis
11.26. Key Trends
11.27. Key Developments

12. Asia Pacific Regenerative Therapies Market Analysis
12.1. Key Findings
12.2. Asia Pacific Regenerative Therapies Market Overview
12.3. Asia Pacific Regenerative Therapies Market Value Share Analysis, By Application
12.4. Asia Pacific Regenerative Therapies Market Forecast, By Application
12.4.1. Musculoskeletal
12.4.2. Oncology
12.4.3. Wound Care
12.4.4. Dental
12.4.5. Ocular
12.4.6. Other Applications
12.5. Asia Pacific Regenerative Therapies Market Value Share Analysis, By Application
12.6. Asia Pacific Regenerative Therapies Market Forecast, By Product
12.6.1. Tissue-engineered Products
12.6.2. Cell Therapies
12.6.3. Gene Therapies
12.6.4. Motor generator
12.6.5. Progenitor & Stem Cell Therapies
12.7. Asia Pacific Regenerative Therapies Market Value Share Analysis, by Country
12.8. Asia Pacific Regenerative Therapies Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. South Korea
12.8.5. Australia
12.8.6. ASEAN
12.8.7. Rest of Asia Pacific
12.9. Asia Pacific Regenerative Therapies Market Analysis, by Country
12.10. China Regenerative Therapies Market Forecast, By Application
12.10.1. Musculoskeletal
12.10.2. Oncology
12.10.3. Wound Care
12.10.4. Dental
12.10.5. Ocular
12.10.6. Other Applications
12.11. China Regenerative Therapies Market Forecast, By Product
12.11.1. Tissue-engineered Products
12.11.2. Cell Therapies
12.11.3. Gene Therapies
12.11.4. Motor generator
12.11.5. Progenitor & Stem Cell Therapies
12.12. India Regenerative Therapies Market Forecast, By Application
12.12.1. Musculoskeletal
12.12.2. Oncology
12.12.3. Wound Care
12.12.4. Dental
12.12.5. Ocular
12.12.6. Other Applications
12.13. India Regenerative Therapies Market Forecast, By Product
12.13.1. Tissue-engineered Products
12.13.2. Cell Therapies
12.13.3. Gene Therapies
12.13.4. Motor generator
12.13.5. Progenitor & Stem Cell Therapies
12.14. Japan Regenerative Therapies Market Forecast, By Application
12.14.1. Musculoskeletal
12.14.2. Oncology
12.14.3. Wound Care
12.14.4. Dental
12.14.5. Ocular
12.14.6. Other Applications
12.15. Japan Regenerative Therapies Market Forecast, By Product
12.15.1. Tissue-engineered Products
12.15.2. Cell Therapies
12.15.3. Gene Therapies
12.15.4. Motor generator
12.15.5. Progenitor & Stem Cell Therapies
12.16. South Korea Regenerative Therapies Market Forecast, By Application
12.16.1. Musculoskeletal
12.16.2. Oncology
12.16.3. Wound Care
12.16.4. Dental
12.16.5. Ocular
12.16.6. Other Applications
12.17. South Korea Regenerative Therapies Market Forecast, By Product
12.17.1. Tissue-engineered Products
12.17.2. Cell Therapies
12.17.3. Gene Therapies
12.17.4. Motor generator
12.17.5. Progenitor & Stem Cell Therapies
12.18. Australia Regenerative Therapies Market Forecast, By Application
12.18.1. Musculoskeletal
12.18.2. Oncology
12.18.3. Wound Care
12.18.4. Dental
12.18.5. Ocular
12.18.6. Other Applications
12.19. Australia Regenerative Therapies Market Forecast, By Product
12.19.1. Tissue-engineered Products
12.19.2. Cell Therapies
12.19.3. Gene Therapies
12.19.4. Motor generator
12.19.5. Progenitor & Stem Cell Therapies
12.20. ASEAN Regenerative Therapies Market Forecast, By Application
12.20.1. Musculoskeletal
12.20.2. Oncology
12.20.3. Wound Care
12.20.4. Dental
12.20.5. Ocular
12.20.6. Other Applications
12.21. ASEAN Regenerative Therapies Market Forecast, By Product
12.21.1. Tissue-engineered Products
12.21.2. Cell Therapies
12.21.3. Gene Therapies
12.21.4. Motor generator
12.21.5. Progenitor & Stem Cell Therapies
12.22. Rest of Asia Pacific Regenerative Therapies Market Forecast, By Application
12.22.1. Musculoskeletal
12.22.2. Oncology
12.22.3. Wound Care
12.22.4. Dental
12.22.5. Ocular
12.22.6. Other Applications
12.23. Rest of Asia Pacific Regenerative Therapies Market Forecast, By Product
12.23.1. Tissue-engineered Products
12.23.2. Cell Therapies
12.23.3. Gene Therapies
12.23.4. Motor generator
12.23.5. Progenitor & Stem Cell Therapies
12.24. Asia Pacific Regenerative Therapies Market Attractiveness Analysis
12.24.1. By Application
12.24.2. By Product
12.25. PEST Analysis
12.26. Key Trends
12.27. Key Developments

13. Middle East & Africa Regenerative Therapies Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Regenerative Therapies Market Overview
13.3. Middle East & Africa Regenerative Therapies Market Value Share Analysis, By Application
13.4. Middle East & Africa Regenerative Therapies Market Forecast, By Application
13.4.1. Musculoskeletal
13.4.2. Oncology
13.4.3. Wound Care
13.4.4. Dental
13.4.5. Ocular
13.4.6. Other Applications
13.5. Middle East & Africa Regenerative Therapies Market Forecast, By Product
13.5.1. Tissue-engineered Products
13.5.2. Cell Therapies
13.5.3. Gene Therapies
13.5.4. Motor generator
13.5.5. Progenitor & Stem Cell Therapies
13.6. Middle East & Africa Regenerative Therapies Market Value Share Analysis, by Country
13.7. Middle East & Africa Regenerative Therapies Market Forecast, by Country
13.7.1. GCC Countries
13.7.2. South Africa
13.7.3. Nigeria
13.7.4. Egypt
13.7.5. Rest of Middle East & Africa
13.8. Middle East & Africa Regenerative Therapies Market Analysis, by Country
13.9. GCC Countries Regenerative Therapies Market Forecast, By Application
13.9.1. Musculoskeletal
13.9.2. Oncology
13.9.3. Wound Care
13.9.4. Dental
13.9.5. Ocular
13.9.6. Other Applications
13.10. GCC Countries Regenerative Therapies Market Forecast, By Product
13.10.1. Tissue-engineered Products
13.10.2. Cell Therapies
13.10.3. Gene Therapies
13.10.4. Motor generator
13.10.5. Progenitor & Stem Cell Therapies
13.11. South Africa Regenerative Therapies Market Forecast, By Application
13.11.1. Musculoskeletal
13.11.2. Oncology
13.11.3. Wound Care
13.11.4. Dental
13.11.5. Ocular
13.11.6. Other Applications
13.12. South Africa Regenerative Therapies Market Forecast, By Product
13.12.1. Tissue-engineered Products
13.12.2. Cell Therapies
13.12.3. Gene Therapies
13.12.4. Motor generator
13.12.5. Progenitor & Stem Cell Therapies
13.13. Nigeria Regenerative Therapies Market Forecast, By Application
13.13.1. Musculoskeletal
13.13.2. Oncology
13.13.3. Wound Care
13.13.4. Dental
13.13.5. Ocular
13.13.6. Other Applications
13.14. Nigeria Regenerative Therapies Market Forecast, By Product
13.14.1. Tissue-engineered Products
13.14.2. Cell Therapies
13.14.3. Gene Therapies
13.14.4. Motor generator
13.14.5. Progenitor & Stem Cell Therapies
13.15. Egypt Regenerative Therapies Market Forecast, By Application
13.15.1. Musculoskeletal
13.15.2. Oncology
13.15.3. Wound Care
13.15.4. Dental
13.15.5. Ocular
13.15.6. Other Applications
13.16. Egypt Regenerative Therapies Market Forecast, By Product
13.16.1. Tissue-engineered Products
13.16.2. Cell Therapies
13.16.3. Gene Therapies
13.16.4. Motor generator
13.16.5. Progenitor & Stem Cell Therapies
13.17. Rest of Middle East & Africa Regenerative Therapies Market Forecast, By Application
13.17.1. Musculoskeletal
13.17.2. Oncology
13.17.3. Wound Care
13.17.4. Dental
13.17.5. Ocular
13.17.6. Other Applications
13.18. Rest of Middle East & Africa Regenerative Therapies Market Forecast, By Product
13.18.1. Tissue-engineered Products
13.18.2. Cell Therapies
13.18.3. Gene Therapies
13.18.4. Progenitor & Stem Cell Therapies
13.19. Middle East & Africa Regenerative Therapies Market Attractiveness Analysis
13.19.1. By Application
13.19.2. By Product
13.20. PEST Analysis
13.21. Key Trends
13.22. Key Developments

14. South America Regenerative Therapies Market Analysis
14.1. Key Findings
14.2. South America Regenerative Therapies Market Overview
14.3. South America Regenerative Therapies Market Value Share Analysis, By Application
14.4. South America Regenerative Therapies Market Forecast, By Application
14.4.1. Musculoskeletal
14.4.2. Oncology
14.4.3. Wound Care
14.4.4. Dental
14.4.5. Ocular
14.4.6. Other Applications
14.5. South America Regenerative Therapies Market Forecast, By Product
14.5.1. Tissue-engineered Products
14.5.2. Cell Therapies
14.5.3. Gene Therapies
14.5.4. Progenitor & Stem Cell Therapies
14.6. South America Regenerative Therapies Market Value Share Analysis, by Country
14.7. South America Regenerative Therapies Market Forecast, by Country
14.7.1. Brazil
14.7.2. Colombia
14.7.3. Argentina
14.7.4. Rest of South America
14.8. South America Regenerative Therapies Market Analysis, by Country
14.9. Brazil Regenerative Therapies Market Forecast, By Application
14.9.1. Musculoskeletal
14.9.2. Oncology
14.9.3. Wound Care
14.9.4. Dental
14.9.5. Ocular
14.9.6. Other Applications
14.10. Brazil Regenerative Therapies Market Forecast, By Product
14.10.1. Tissue-engineered Products
14.10.2. Cell Therapies
14.10.3. Gene Therapies
14.10.4. Progenitor & Stem Cell Therapies
14.11. Colombia Regenerative Therapies Market Forecast, By Application
14.11.1. Musculoskeletal
14.11.2. Oncology
14.11.3. Wound Care
14.11.4. Dental
14.11.5. Ocular
14.11.6. Other Applications
14.12. Colombia Regenerative Therapies Market Forecast, By Product
14.12.1. Tissue-engineered Products
14.12.2. Cell Therapies
14.12.3. Gene Therapies
14.12.4. Progenitor & Stem Cell Therapies
14.13. Argentina Regenerative Therapies Market Forecast, By Application
14.13.1. Musculoskeletal
14.13.2. Oncology
14.13.3. Wound Care
14.13.4. Dental
14.13.5. Ocular
14.13.6. Other Applications
14.14. Argentina Regenerative Therapies Market Forecast, By Product
14.14.1. Tissue-engineered Products
14.14.2. Cell Therapies
14.14.3. Gene Therapies
14.14.4. Progenitor & Stem Cell Therapies
14.15. Rest of South America Regenerative Therapies Market Forecast, By Application
14.15.1. Musculoskeletal
14.15.2. Oncology
14.15.3. Wound Care
14.15.4. Dental
14.15.5. Ocular
14.15.6. Other Applications
14.16. Rest of South America Regenerative Therapies Market Forecast, By Product
14.16.1. Tissue-engineered Products
14.16.2. Cell Therapies
14.16.3. Gene Therapies
14.16.4. Progenitor & Stem Cell Therapies
14.17. South America Regenerative Therapies Market Attractiveness Analysis
14.17.1. By Application
14.17.2. By Product
14.18. PEST Analysis
14.19. Key Trends
14.20. Key Developments

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix

15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Applications
15.2.3.2. M&A Key Players, Forward Integration and Backward Integration

15.3. Company Profiles: Key Players
15.3.1. Acelity L.P. Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Development Footprint
15.3.2. Mesoblast Ltd.
15.3.3. Nuo Therapeutics, Inc. (Cytomedix).
15.3.4. Astellas Pharma US, Inc.
15.3.5. Organovo Holdings Inc.
15.3.6. Orgenesis Inc.
15.3.7. Sanofi.
15.3.8. Athersys, Inc.
15.3.9. Shire Pharmaceuticals Limited.
15.3.10. Cytori Therapeutics Inc.
15.3.11. Other

16. Primary Key Insights
  • INQUIRE BEFORE BUYING